Host: Michael Krychman, MD 


  Guest: Sheryl A. Kingsberg, PhD 



  
    Flibanserin's approval by the FDA for women with hypoactive sexual desire disorder (HSDD), touted by the press as the "Pink Viagra," created an enormous amount of media hype across the nation. But the facts on this drug's mechanism of action, intended benefits, adverse effects, and efficacy borne in clinical trials have gone largely under the radar. Joining Dr. Michael Krychman to discuss the rise of flibanserin and its key takeaways for clinicians is Dr. Sheryl Kingsberg, Chief of the Division of Behavioral Medicine in the Department of OB/GYN and Professor in the Departments of Reproductive Biology and Psychiatry at Case Medical Center University Hospitals in Cleveland, Ohio. 

Flibanserin 101: Benefits vs Risks for Women with Hypoactive Sexual Desire Disorder

Talking to a patient about sexual health can be as uncomfortable for the medical professional as it may be for the patient. This groundbreaking series is dedicated to helping healthcare professionals address the needs of the estimated 30-45 percent of patients who may be suffering from issues related to this under-discussed but critical aspect of patient care. SexMed presents the latest advances and current perspectives in this field, reminding us all that sexual health is integral to general health. Topics examine a wide range of physical, psychological, and sociocultural issues that impact sexual function and health.

Science & Medicine

Natural Sciences

Social Sciences

Medicine

Health

Alternative Health

Self-Help

Sexuality

Fitness & Nutrition

Host: Paul Doghramji, MD 


  Guest: Megan Arnot 



  
    Menopause is an inevitable transition in every woman’s life, but what if engaging in a basic physiological need like sex could delay its onset? Researching this potential connection is Megan Arnot, a Ph.D. candidate in the Department of Anthropology at the University College London. As the lead author of the study, she walks us through her findings and the range of factors they investigated, like the type of sexual activity and whether or not women lived with a partner.

Investigating the Link Between Sexual Activity & Menopause Onset

Guest: Sheryl A. Kingsberg, PhD 


Guest: Brooke M. Faught, DNP, WHNP-BC,NCMP, IF 


Guest: Risa Kagan, MD, FACOG, CCD, NCMP 


Guest: James A. Simon, MD, CCD, NCMP, IF, FACOG 



  An average of 37.5 million menopausal women in the US between the ages of 45 and 64 experience symptoms such as hot flashes and joint pain, but there are other symptoms that we rarely talk about: symptoms like vaginal dryness and dyspareunia. Featuring a patient and a panel of experts, this discussion reviews strategies that can be used to help patients feel comfortable in bringing up their struggles with menopause along with how we can help relieve women from their pain. ©2019 NP-INR-US-00214 09/19

Having the Talk: Painful Sex Due to Menopause

Host: Paul Doghramji, MD 


  Guest: Alexander W. Pastuszak, MD, PhD 



  
    Put your knowledge of male infertility diagnosis and treatment strategies to the test with Dr. Alexander Pastuszak, an Assistant Professor at the University of Utah School of Medicine, as he breaks down its common causes and how we can improve care for our male patients.

Male Infertility Insights: Causes, Diagnosis, & Treatment

Host: Paul Doghramji, MD 


  Guest: Alexander W. Pastuszak, MD, PhD 



  
    Even though hypogonadism is common among men, there are still some misconceptions surrounding it. So to learn more about how we can better diagnose and treat hypogonadism in our male patients, Dr. Paul Doghramji sits down with Dr. Alexander Pastuszak, an Assistant Professor at the University of Utah School of Medicine.

Male Hypogonadism: More Than Just Low Testosterone

Host: Lee Philip Shulman, MD, FACOG, FACMG 


Guest: Sheryl A. Kingsberg, PhD 


Guest: David J. Portman, MD 



  The underdiagnosis and undermanagement of hypoactive sexual desire disorder is in large part due to clinicians’ reluctance to raise issues of sexual health and functioning in their female patients, in addition to a lack of awareness of diagnostic screeners available and evolving therapeutic approaches.  To help close these gaps in care, this discussion will identify the symptoms of HSDD and the barriers clinicians face that inhibit the appropriate diagnosis and management of this condition. The faculty will also identify the screening tools that allow for accurate diagnosis of HSDD as well as the therapeutic modalities currently available and under clinical development to manage HSDD, including their benefits and potential side effects.

Flibanserin 101: Benefits vs Risks for Women with Hypoactive Sexual Desire Disorder

Download our free app to listen on your phone